Dericip 77mg/23mg Tablet

Introduction

Dericip is a prescription medication that contains two active ingredients: Etofylline and Theophylline. It is commonly used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). This medication is available in tablet form and is sold under the brand name Dericip.

Uses

Dericip is primarily prescribed to manage and alleviate the symptoms associated with asthma and COPD. It helps to relax the muscles in the airways, allowing for easier breathing. This medication is often used as a maintenance treatment to control chronic respiratory conditions and reduce the frequency and severity of symptoms.

Dosage and Administration

The dosage of Dericip may vary depending on the individual’s specific condition and response to treatment. Follow the instructions provided by your healthcare professional. Generally, the recommended dose for adults is one tablet taken orally, usually two to three times daily. The tablets should be swallowed whole with water, and it is best to take them with food to minimize the risk of stomach upset.

Mechanism of Action

Dericip contains two active ingredients, Etofylline and Theophylline, which work together to relax the smooth muscles in the airways. Etofylline helps to open up the air passages by dilating the bronchial tubes, while Theophylline helps to reduce inflammation and improve airflow. By targeting these key mechanisms, Dericip helps to alleviate the symptoms of asthma and COPD, making it easier for individuals to breathe.

Side Effects

Common side effects may include nausea, vomiting, headache, and stomach upset. These side effects are usually mild and temporary. However, if you experience any severe or persistent side effects, such as rapid or irregular heartbeat, chest pain, or difficulty breathing, seek medical attention immediately.

Drug Interactions

Dericip may interact with other medications, including certain antibiotics, antifungal medications, and medications used to treat seizures or heart conditions. Inform your healthcare professional about all the medications you are currently taking, including prescription medications, over-the-counter drugs, and herbal supplements, to avoid potential drug interactions.

Precautions

Before taking Dericip, discuss your medical history and any underlying conditions with your healthcare professional. Inform them of any allergies, heart problems, liver or kidney disease, or any other significant health issues. This medication may not be suitable for everyone, and your healthcare professional will evaluate the potential benefits and risks before prescribing it to you.

Storage

Patient Tips

• Take Dericip exactly as prescribed by your healthcare professional.
• If you have any questions or concerns about your treatment, do not hesitate to reach out to your healthcare professional.
• Do not abruptly stop taking Dericip without consulting your healthcare professional, as this may lead to a worsening of symptoms.
• Avoid consuming excessive amounts of caffeine while taking this medication, as it may increase the risk of side effects.
• Attend regular follow-up appointments with your healthcare professional to monitor your progress and adjust your treatment plan if necessary.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Bronchodilators – Side effects (NHS UK) [Accessed 29 Jun. 2024] (online) Available at:
• Do-Do Chesteze (Health Professionals SmPC) Available at:
• Etofylline (International database) (Drugs.com) [Accessed 3 Jun. 2024] (online) Available at:
• theophylline (RX) [Accessed 15 Jun. 2024] (online) Available at:
• Theophylline (MedlinePlus) [Accessed 9 Jun. 2024] (online) Available at:
• Pardeshi CV, Agnihotri VV, Patil KY, Pardeshi SR, Surana SJ. Mannose-anchored N,N,N-trimethyl chitosan nanoparticles for pulmonary administration of etofylline. Int J Biol Macromol. 2020 Dec 15;165(Pt A):445-459. doi: 10.1016/j.ijbiomac.2020.09.163. Epub 2020 Sep 25. [Accessed 9 Jun. 2024] Available at: